Clinical Trial Update: A Study of SGN-ALPV in Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Seagen's Phase 1 study of SGN-ALPV in advanced solid tumors has been terminated; the trial evaluated multiple cancers including ovarian, endometrial, and non-sm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Endometrial Cancer
• Gastroesophageal Junction Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Stomach Cancer
• Testicular Cancer

Drugs mentioned

• SGN-ALPV

Snippet

Sponsor: Seagen Inc. | Conditions: Ovarian Neoplasms, Endometrial Neoplasms | Phase 1 | Status: TERMINATED